Zhejiang Huakang Pharmaceutical Co., Ltd.
Shanghai Stock Exchange 605077.SS
Zhejiang Huakang Pharmaceutical Co., Ltd. Operating Income for the year ending December 31, 2023: USD 60.16 M
Zhejiang Huakang Pharmaceutical Co., Ltd. Operating Income is USD 60.16 M for the year ending December 31, 2023, a 18.87% change year over year. Operating income is the profit earned by a company from its normal business operations before interest and taxes are deducted.
-
Zhejiang Huakang Pharmaceutical Co., Ltd. Operating Income for the year ending December 31, 2022 was USD 50.61 M, a 25.29% change year over year.
-
Zhejiang Huakang Pharmaceutical Co., Ltd. Operating Income for the year ending December 31, 2021 was USD 40.39 M, a -25.97% change year over year.
-
Zhejiang Huakang Pharmaceutical Co., Ltd. Operating Income for the year ending December 31, 2020 was USD 54.56 M, a 22.35% change year over year.
-
Zhejiang Huakang Pharmaceutical Co., Ltd. Operating Income for the year ending December 31, 2019 was USD 44.59 M, a 36.73% change year over year.
Key data
| Date | Operating Income | EBIT | EBITDA | Net Income |
|---|
Market news
Loading...
Shanghai Stock Exchange: 605077.SS
| CEO | Mr. Deshui Chen |
| IPO Date | Feb. 9, 2021 |
| Location | China |
| Headquarters | No.18, Huagong Road |
| Employees | 1,350 |
| Sector | Materials |
| Industries | |
Description
Zhejiang Huakang Pharmaceutical Co., Ltd. engages in the research, production, and sale of polyols worldwide. Its products include xylitol, a polyol with close to sugar sweetness; sorbitol, a sugar alcohol being white crystal powder; maltitol, a sugar alcohol; xylose that is used in xylitol production; and L-arabinos, which can be used as sucrose replacement or additives. The company is based in Kaihua County, China.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email